ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.61 HKD | -5.00% |
|
+1.41% | -15.09% |
| May. 28 | Hong Kong Stocks Stayed Flat Despite Shanghai’s Property Cuts, Beijing’s Huge Investment Plan | MT |
| May. 28 | Alibaba Health Shares Rise on Earnings Beat | DJ |
| Sales 2024 | 27.03B 0 0 | Sales 2025 * | 31.25B 0 0 | Capitalization | 56.7B 0 0 |
|---|---|---|---|---|---|
| Net income 2024 | 883M - - | Net income 2025 * | 1.59B - - | EV / Sales 2024 | 1.89 x |
| Net cash position 2024 * | 10.91B 0 0 | Net cash position 2025 * | 11.15B 0 0 | EV / Sales 2025 * | 1.46 x |
| P/E ratio 2024 |
50.7
x | P/E ratio 2025 * |
32.6
x | Employees | 1,435 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 37.22% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | -1.55% | ||
| 1 week | +12.76% | ||
| Current month | +15.85% | ||
| 1 month | +19.87% | ||
| 3 months | +17.28% | ||
| 6 months | -10.59% | ||
| Current year | -10.38% |
1 week
3.42
3.87
1 month
2.903.87
Current year
2.594.30
1 year
2.595.82
3 years
2.5918.22
5 years
2.5930.15
10 years
2.5930.15
| Managers | Title | Age | Since |
|---|---|---|---|
Di Fan Shen
CEO | Chief Executive Officer | 46 | - |
Yan Wu Tu
DFI | Director of Finance/CFO | 46 | 19-08-31 |
Shun Yan Zhu
CHM | Chairman | 53 | 20-03-15 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yi Hong Wu
BRD | Director/Board Member | 56 | 23-08-10 |
Shun Yan Zhu
CHM | Chairman | 53 | 20-03-15 |
Rong Shao
BRD | Director/Board Member | 62 | 23-08-10 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.59% | 305 M€ | +9.61% | ||
| 1.56% | 92 M€ | +12.65% | - | |
| 1.56% | 11 M€ | +9.34% | - | |
| 1.42% | 0 M€ | 0.00% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-11 | 3.61 | -5.00% | 46 411 870 |
| 24-06-11 | 3.8 | -1.55% | 102,160,000 |
| 24-06-07 | 3.86 | +2.12% | 117,056,500 |
| 24-06-06 | 3.78 | +6.48% | 115,133,000 |
| 24-06-05 | 3.55 | +2.60% | 69,111,340 |
Delayed Quote Hong Kong S.E., June 11, 2024 at 04:08 am EDT
More quotes
Alibaba Health Information Technology Limited is specialized in the direct sale of pharmaceuticals. The turnover is divided across the following activities:
- direct sale of pharmaceuticals (85.2%);
- online sale of pharmaceuticals(12.7%);
- direct healthcare services (1.8%);
- online healthcare services and monitoring of pharmaceuticals (0.3%).
The turnover is divided into the revenue sources of product sales (80.8%) and services (19.2%).
The geographical breakdown of the turnover is as follows: mainland China (95.8%) and Hong Kong (4.2%).
Sector
Drug Retailers
Calendar
2024-11-25
- Q2 2025 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
3.526
CNY
Average target price
4.966
CNY
Spread / Average Target
+40.84%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -10.38% | 7.94B | |
| -38.99% | 13.75B | |
| -36.57% | 10.33B | |
| +4.30% | 5.86B | |
| -14.62% | 5.69B | |
| -3.21% | 4.65B | |
| +67.88% | 4.46B | |
| -8.77% | 3.79B | |
| -22.93% | 3.05B | |
| -14.25% | 2.83B |
- Stock Market
- Equities
- 241 Stock
